Tags

Type your tag names separated by a space and hit enter

inhibitor

(in-hib′ĭt-ŏr )

[L. inhibere, to hold back, restrain]
An agent that blocks a cellular receptor, stops a chemical reaction, prevents an enzyme from working, or suppresses a muscle or nerve.

acetylcholinesterase inhibitor

SEE: Cholinesterase inhibitor.

alpha-2 plasmin inhibitor

SEE: Alpha-2 antiplasmin.

alpha-glucosidase inhibitor

An oral drug that lowers blood sugars by preventing carbohydrate absorption from the gastrointestinal tract.

alpha-reductase inhibitor

A medication to treat benign prostatic hyperplasia. It blocks the conversion of testosterone to dihydrotestosterone.

angiotensin-converting-enzyme inhibitor

ABBR: ACE inhibitor Any of the therapeutic agents that inhibit conversion of angiotensin I to angiotensin II. ACE inhibitors are used to treat hypertension and heart failure and to protect kidney function in patients with diabetes mellitus.

aromatase inhibitor

Any of a class of drugs that block the synthesis of estrogen in the body. A number of these agents have been developed to treat breast cancer, which is often a hormone-responsive malignancy.

attachment inhibitor

SEE: Entry inhibitor.

bone resorption inhibitor

Any of a class of drugs that prevent or retard osteoporosis. Examples include the bisphosphonates.
Descriptive text is not available for this imagePatients with achalasia should avoid these medications because bisphosphonates may cause inflammation and ulceration in the esophagus.

catechol-O-methyltransferase inhibitor

ABBR: COMT inhibitor An inhibitor such as entacapone or tolcapone used to treat the “wearing off” phenomenon of Parkinson disease. “Wearing off” is the reduction of the rate at which levodopa is metabolized. The COMT inhibitors reduce this rate and prolong the effectiveness of levadopa.

chitin synthase inhibitor

Any agent that prevents chitin, a critical component of fungal cell walls, from forming. Agents from this class may be used to treat serious fungal infections, such as coccidiomycosis.

cholesteryl ester transfer protein inhibitor

Any drug that inhibits the transfer of cholesteryl esters from high-density lipoproteins (HDLs) to other lipoproteins. Drugs from this class increase HDL levels, potentially improving the lipid profiles of patients and decreasing their risk of atherosclerosis.

cholinesterase inhibitor

ABBR: ChEI Any of a class of drugs that prevent the degradation of the neurotransmitter acetylcholine, which is involved in memory and learning. Drugs from this class are used to treat Alzheimer dementia.
SYN: SEE: acetylcholinesterase inhibitor

competitive inhibitor

1. A chemical that binds to or blocks another reagent from participating in a reaction.
2. A medication, hormone, or other intercellular messenger that binds and blocks the cellular receptor or target enzyme of another agent. Drugs that act by competitive inhibition may treat or prevent disease by inactivating pathogenic enzymes or by blocking the effects of hormones or precursor molecules. For example, protease inhibitors interfere with production of HIV by binding and inactivating the protease enzyme; selective estrogen-receptor modulators limit the impact of estrogen by replacing this hormone on cells sensitive to its effects.

cyclooxygenase inhibitor

Any agent that suppresses inflammation by blocking the inflammatory effects of cyclooxygenase.

dipeptidyl peptidase-4 inhibitor

ABBR: DPP-4 inhibitor SEE: Gliptin.

direct thrombin inhibitor

ABBR: DTI Any medication or substance that interferes with the coagulation of blood by blocking the action of thrombin. Unlike heparins, which are anticoagulants that require the presence of antithrombin to inactivate thrombin, DTIs exert their effects without an intermediary. DTIs can be used to treat and prevent clots in both arteries and veins (heparin and warfarin are usually preferred for these uses). They are an alternative to heparin in patients with a history of heparin-induced thrombocytopenia. The primary side effect of DTIs is bleeding.

DPP-4 inhibitor

dipeptidyl peptidase-4 inhibitor.

dual reuptake inhibitor

An antidepressant medication that works by blocking the reuptake of both serotonin and norepinephrine.

entry inhibitor

Any agent that prevents a pathogen, e.g., HIV, from binding to cell membranes and infecting cells.
SYN: SEE: attachment

factor Xa inhibitor

Any drug that prevents blood coagulation by interfering with the activity of coagulation Factor Xa. Examples include: apixaban, edoxaban, and rivaroxaban.

fusion inhibitor

Any drug that prevents a virus from attaching itself to the membrane of a vulnerable cell.

glycoprotein IIB/IIIa receptor inhibitor

Any of a class of drugs that block the fibrinogen receptor on the surface of platelets. Drugs from this class are used to treat acute myocardial infarction, unstable angina pectoris, and other acute coronary syndromes. The most common side effect of treatment with these drugs is bleeding.

helicase-primase inhibitor

Any drug that blocks the replication of herpes simplex virus by targeting enzymes crucial to viral DNA synthesis.

HMG CoA enzyme inhibitor

SEE: Statin.

integrase inhibitor

ABBR: INSTI Any agent that prevents HIV from inserting its viral DNA into host cell chromosomes.

integrase strand transfer inhibitor

Any antiretroviral drug that blocks the effect of integrase.
SEE: integrase

matrix metalloproteinase inhibitor

An agent that inhibits cancer cells by blocking their abilities to invade tissues, demand new blood supply, and metastasize.

metalloprotease inhibitor

SEE: Metalloproteinase inhibitor.

metalloproteinase inhibitor

Any of numerous compounds that inhibit the activity of the metalloproteinase family of enzymes. These agents share the ability to suppress or eliminate the enzyme activity of the metalloproteinases. Agents identified in this group include the tetracycline antibiotics, numerous specially designed synthetic peptides and proteins, chemicals such as ethylenediaminetetra-acetic acid (EDTA), and a variety of agents used in cancer chemotherapy.
SYN: SEE: metalloprotease inhibitor

monoamine oxidase inhibitor

ABBR: MAOI Any of a group of drugs that can be used to treat depression and Parkinson disease. Nonselective versions of these medications produced hypertensive crises and other severe side effects when they were taken with tyramine-containing foods (some cheeses) and several other drugs. Newer members of this class of drugs do not have these effects, but should be used with caution, esp. by those taking selective serotonin reuptake inhibitors.
Descriptive text is not available for this imageMAOIs may have unfavorable drug-drug interactions with many anesthetics and should be discontinued approximately 2 weeks before surgery.

SEE: tyramine

neuraminidase inhibitor

Any of a class of antiviral drugs that block neuraminidase, which helps the influenza virus to bud from cells it has infected so that it can spread to other ciliated epithelial cells of the respiratory tract. Agents in this class include oseltamivir and zanamivir.

nonnucleoside analog reverse transcriptase inhibitor

ABBR: NNRTI Any of a class of antiretroviral drugs used to treat those infected with HIV. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.

nucleoside reverse transcriptase inhibitor

ABBR: NRTI Any of a class of antiretroviral drugs used to treat patients with HIV infection. NRTIs prevent transcription of viral RNA to host DNA by interfering with the action of the enzyme reverse transcriptase. Zidovudine, dideoxyinosine, zalcitabine, d4T, and abacavir are NRTIs.
SEE: reverse transcriptase inhibitor

PCSK9 inhibitor

Any of a class of drugs that bind to cellular receptors for low-density lipoproteins (LDLs). They are used to improve serum cholesterol levels by improving the clearance of LDLs from the circulation.

phosphodiesterase inhibitor

ABBR: PDE inhibitor Any agent that blocks phosphodiesterase, inhibiting the production of second messengers within cells, such as cyclic adenosine monophosphate or cyclic glucose monophosphate. Drugs that inhibit PDE include sildenafil and other agents used as positive inotropes and vasodilators in heart failure.

proprotein convertase subtilisin-kexin type 9 inhibitor

A monoclonal antibody used to treat elevated low density lipoprotein cholesterol levels.

prostaglandin inhibitor

A substance that inhibits the production of prostaglandins. Nonsteroidal and steroidal anti-inflammatory agents are two major categories of such inhibitors.

protease inhibitor

1. A substance that inhibits the action of enzymes.
2. Any of a class of medications that prevent immature virions (as of hepatitis viruses or HIV) from assembling into structures capable of replication.

proton pump inhibitor

ABBR: PPI Any of a class of medications that eliminate acid production in the stomach. These drugs are used to treat peptic ulcers, gastroesophageal reflux disease, infection with Heliobacter pylori, and related disorders. Omeprazole and lansoprazole are members of this drug class.

reverse transcriptase inhibitor

ABBR: RTI Any of a class of antiretroviral agents that competitively inhibit the reverse transcriptase enzyme of HIV and other viruses.
SEE: antiretroviral

selective serotonin reuptake inhibitor

ABBR: SSRI Any of a class of drugs that interfere with serotonin transport and are used to treat depression, obsessive-compulsive behaviors, eating disorders, and social phobias. Examples include fluoxetine (Prozac), paroxetine (Paxil), and sertraline.
Descriptive text is not available for this imageThe use of SSRIs in the treatment of depression may sometimes be associated with an increased risk of suicide, esp. during the initiation of treatment. The risk is greatest among children and adolescents. All patients who begin treatment with SSRIs should be monitored closely for evidence that they intend to harm themselves.

serine protease inhibitor

ABBR: serpin Any of the compounds that inhibit platelet function and coagulation. Serpins have been used to reduce deposition of microemboli in cases of disseminated intravascular coagulation associated with sepsis.

serotonin and norepinephrine reuptake inhibitor

ABBR: SNRI An antidepressant medication (such as duloxetine or venlafaxine) that elevates mood by blocking neurons from taking up both norepinephrine and serotonin. Combined reuptake inhibitors differ from medications such as sertraline (Zoloft) or fluoxetine (Prozac), which are relatively selective serotonin reuptake inhibitors, and from tricyclic antidepressants, which primarily prevent the reuptake of norepinephrine by brain cells. SNRIs treat neuropathic pain as well as depression.

sodium-glucose cotransporter 2 inhibitor

Any drug, such as dapaglifozin or canagliflozin, that reduces serum blood sugars by increasing the urinary excretion of glucose.

tubulin inhibitor

Any drug that blocks the polymerization of microtubules in cells, and thereby preventing mitosis from occurring. An example of a drug from this class is colchicine.

tumor necrosis factor alpha inhibitor

A drug that blocks the effects of tumor necrosis factor alpha (TNF-α), a biologically active cytokine that is a critical element of the inflammatory response. Such drugs, which include adalimumab, etanercept, and infliximab, are agents used to treat autoimmune illnesses such as rheumatoid arthritis.
Descriptive text is not available for this imageBecause these drugs are immunologically active, patients with active infection or those with chronic infections such as tuberculosis should not use them. These agents also sometimes increase the risk of cancers and have rarely been associated with demyelinating diseases of the central nervous system such as multiple sclerosis.

vasopeptidase inhibitor

Any of a class of medications that blocks the actions of both angiotensin-converting enzymes (ACE) and neural endopeptidase. Drugs from this class may be used to treat heart failure.

visceral adipose tissue-derived serine protease inhibitor

SEE: Vaspin.

xanthine oxidase inhibitor

Any drug, such as allopurinol or febuxostat, that decreases serum uric acid concentrations by inhibiting the enzyme xanthine oxidase.

inhibitor is a sample topic from the Taber's Medical Dictionary.

To view other topics, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Learn more.

Citation

Venes, Donald, editor. "Inhibitor." Taber's Medical Dictionary, 23rd ed., F.A. Davis Company, 2017. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/763157/all/sodium_glucose_cotransporter_2_inhibitor.
Inhibitor. In: Venes D, ed. Taber's Medical Dictionary. 23rd ed. F.A. Davis Company; 2017. https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/763157/all/sodium_glucose_cotransporter_2_inhibitor. Accessed August 17, 2019.
Inhibitor. (2017). In Venes, D. (Ed.), Taber's Medical Dictionary. Available from https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/763157/all/sodium_glucose_cotransporter_2_inhibitor
Inhibitor [Internet]. In: Venes D, editors. Taber's Medical Dictionary. F.A. Davis Company; 2017. [cited 2019 August 17]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/763157/all/sodium_glucose_cotransporter_2_inhibitor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - inhibitor ID - 763157 ED - Venes,Donald, BT - Taber's Medical Dictionary UR - https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/763157/all/sodium_glucose_cotransporter_2_inhibitor PB - F.A. Davis Company ET - 23 DB - Nursing Central DP - Unbound Medicine ER -